HRSA
-
HHS plan to address ‘overprescribing’ of psychiatric medications
While the initiative was greeted with cheers of support at the MAHA Institute summit, many behavioral health specialists warned the effort risks stigmatizing care and reducing treatment options.
-
HHS agency signals drug rebate program redux with request for information
The RFI is the Trump administration’s next move to get its drug pricing rebate program back on track after hospital groups blocked it last year.